Porcza Laura M, Simms Claire, Chopra Mridula
Institute of Biomedical and Biomolecular Science (IBBS), School of Pharmacy and Biomedical Sciences, University of Portsmouth, Hampshire, Portsmouth PO1 2DT, UK.
Diseases. 2016 Sep 30;4(4):30. doi: 10.3390/diseases4040030.
Cancer is a leading cause of death worldwide and poses a challenge to treatment. With overwhelming evidence of the role played by diet and lifestyle in cancer risk and prevention, there is a growing interest into the search for chemopreventative or chemotherapeutic agents derived from natural products. Honey is an important source of bioactive compounds derived from plants and recent years have seen an increased interest in its anticancer properties. This review examines the role of honey in targeting key hallmarks of carcinogenesis, including uncontrolled proliferation, apoptosis evasion, angiogenesis, growth factor signalling, invasion, and inflammation. The evidence for honey as an adjunct to conventional cancer therapy is also presented. The review also highlights gaps in the current understanding and concludes that, before translation of evidence from cell culture and animal studies into the clinical setting, further studies are warranted to examine the effects of honey at a molecular level, as well as on cells in the tumour environment.
癌症是全球主要的死亡原因之一,对治疗构成挑战。鉴于饮食和生活方式在癌症风险和预防中所起作用的证据确凿,人们越来越有兴趣寻找源自天然产物的化学预防或化学治疗药物。蜂蜜是源自植物的生物活性化合物的重要来源,近年来人们对其抗癌特性的兴趣与日俱增。本综述探讨了蜂蜜在针对致癌作用的关键特征方面的作用,包括不受控制的增殖、逃避细胞凋亡、血管生成、生长因子信号传导、侵袭和炎症。还介绍了蜂蜜作为传统癌症治疗辅助手段的证据。该综述还强调了当前认识中的差距,并得出结论,在将细胞培养和动物研究的证据转化为临床应用之前,有必要进行进一步研究,以在分子水平以及肿瘤环境中的细胞上研究蜂蜜的作用。